![David J. Maloney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David J. Maloney
Oprichter bij
Veralox Therapeutics, Inc.
Profiel
David J.
Maloney is the founder of Veralox Therapeutics, Inc. since 2017, holding the title of Chief Scientific Officer.
Formerly, a Vice President & Head-Translational Medicine at Rebus Holdings, Inc. in 2017.
Education includes a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
Actieve functies van David J. Maloney
| Bedrijven | Functie | Begin |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Oprichter | 01-01-2017 |
Eerdere bekende functies van David J. Maloney
| Bedrijven | Functie | Einde |
|---|---|---|
| INSPYR THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2017 |
Opleiding van David J. Maloney
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Rebus Holdings, Inc.
 Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Health Technology |
